Returning for its 15th anniversary this September, the World Clinical Biomarkers & Companion Diagnostics Summit will unite 600+ industry leaders across biopharma, CDx developers, testing labs, regulators, and payers to advance clinical biomarker strategies and accelerate drug-diagnostics to market for improved patient diagnosis, stratification, and monitoring.

See the event details here.